These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29485940)

  • 1. Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.
    Hall ES; Wexelblatt SL; Greenberg JM
    Popul Health Manag; 2018 Dec; 21(6):486-492. PubMed ID: 29485940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures.
    Hall ES; McAllister JM; Wexelblatt SL
    Popul Health Manag; 2019 Feb; 22(1):19-24. PubMed ID: 29893624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
    Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR
    J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization.
    Percy Z; Brokamp C; McAllister JM; Ryan P; Wexelblatt SL; Hall ES
    J Pediatr; 2020 Jul; 222():52-58.e1. PubMed ID: 32423682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
    Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
    JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.
    Honein MA; Boyle C; Redfield RR
    Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30655335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse.
    Wexelblatt SL; Ward LP; Torok K; Tisdale E; Meinzen-Derr JK; Greenberg JM
    J Pediatr; 2015 Mar; 166(3):582-6. PubMed ID: 25454935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome.
    Walsh MC; Crowley M; Wexelblatt S; Ford S; Kuhnell P; Kaplan HC; McClead R; Macaluso M; Lannon C;
    Pediatrics; 2018 Apr; 141(4):. PubMed ID: 29514974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prenatal Opioid Exposure Within Health Administrative Databases.
    Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33376211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal drug use and its effect on neonates: a population-based study in Washington State.
    Creanga AA; Sabel JC; Ko JY; Wasserman CR; Shapiro-Mendoza CK; Taylor P; Barfield W; Cawthon L; Paulozzi LJ
    Obstet Gynecol; 2012 May; 119(5):924-33. PubMed ID: 22525903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Abstinence Syndrome: An Uncontrollable Epidemic.
    MacMullen NJ; Samson LF
    Crit Care Nurs Clin North Am; 2018 Dec; 30(4):585-596. PubMed ID: 30447815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
    Hussaini KS; Garcia Saavedra LF
    Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.
    Patrick SW; Davis MM; Lehmann CU; Cooper WO
    J Perinatol; 2015 Aug; 35(8):650-5. PubMed ID: 25927272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of State-Led Surveillance of Neonatal Abstinence Syndrome - Six U.S. States, 2018-2021.
    Jilani SM; West K; Jacobus-Kantor L; Ali MM; Nyakeriga A; Lake-Burger H; Robinson M; Barnes AE; Jewell T; Gallaway S
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):37-42. PubMed ID: 35025857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal prepregnancy surgery and risk of neonatal abstinence syndrome in future newborns: a longitudinal cohort study.
    Auger N; Low N; Carrier FM; Ayoub A; Luu TM
    CMAJ; 2019 Jul; 191(28):E779-E786. PubMed ID: 31308006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing the statewide incidence of neonatal abstinence syndrome in real time: the West Virginia experience.
    Umer A; Loudin S; Maxwell S; Lilly C; Stabler ME; Cottrell L; Hamilton C; Breyel J; Mullins C; John C
    Pediatr Res; 2019 Apr; 85(5):607-611. PubMed ID: 30287893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
    DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
    Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal opioid use disorder and neonatal abstinence syndrome in northwest Ontario: a 7-year retrospective analysis.
    Dooley J; Ryan G; Gerber Finn L; Bollinger M; Matsumoto CL; Hopman WM; Kelly L
    Can J Rural Med; 2018; 23(2):39-44. PubMed ID: 29547380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.